Erratum: EMerging BiomARKers in inflammatory bowel disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for crohn's disease activity: Role of cross-sectional imaging (American Journal of Gastroenterology (2013) 108 (1891-1900) DOI: 10.1038/ajg.2013.354)

William A. Faubion, Joel G. Fletcher, Sharon O'Byrne, Brian G. Feagan, Willem J.S. De Villiers, Bruce Salzberg, Scott Plevy, Deborah D. Proctor, John F. Valentine, Peter D. Higgins, Jeffrey M. Harris, Lauri Diehl, Lilyan Wright, Gaik Wei Tew, Diana Luca, Karen Basu, Mary E. Keir

Research output: Contribution to journalComment/debate

1 Scopus citations
Original languageEnglish (US)
Number of pages1
JournalAmerican Journal of Gastroenterology
Volume109
Issue number5
DOIs
StatePublished - May 2014

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this